Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05124119 · ClinicalTrials.gov registry record
Strategies to Enhance Recruitment and Retention of Black Individuals Into Clinical Trials for Substance Use Disorders
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 65
- Enrollment target
NCT05124119: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT05124119 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05124119 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
The overall goal of this research project will be to obtain feedback from consumers to help develop a manual called I-DREM (Innovative Development of Research Engagement Manual). The researchers hope to learn information from the consented participants to help map out solutions to improve recruitment of African American/Black individuals into Substance Abuse Disorder (SUD) clinical trials.
Primary Outcome
To conduct focus groups among Black Consumer stakeholders with lived substance use experience to understand the factors that may or may not affect their willingness to participate in prospective substance use disorder (SUD) clinical trials.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2024-07-31 |
What the finished NCT05124119 record still lists
NCT05124119 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 65 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05124119 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05124119 about?
NCT05124119 is a clinical study titled "Strategies to Enhance Recruitment and Retention of Black Individuals Into Clinical Trials for Substance Use Disorders". The overall goal of this research project will be to obtain feedback from consumers to help develop a manual called I-DREM (Innovative Development of Research Engagement Manual). The researchers hope to learn information from the consented participants to help map out solutions to improve recruitmen...
What is the current status of trial NCT05124119?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2022-04-01. Estimated completion is 2024-07-31.
Who is sponsoring clinical trial NCT05124119?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI